GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (2)
  • Medicine  (2)
  • 1
    In: Journal of Internal Medicine, Wiley, Vol. 277, No. 6 ( 2015-06), p. 717-726
    Abstract: Recent metabolomic, experimental and clinical studies have demonstrated that trimethylamine‐N‐oxide ( TMAO ), a microbiota‐dependent metabolite from dietary phosphatidylcholine and carnitine, is a strong predictor of coronary artery disease ( CAD ). This finding suggests a link between the gut microbiota and atherosclerosis. The potential impact of TMAO in chronic heart failure ( HF ) is unknown. We hypothesized that TMAO levels would provide prognostic information about adverse outcomes in chronic HF . Design Prospective, observational study including 155 consecutive patients with chronic HF . In addition, 100 patients with stable CAD without HF and 33 matched healthy individuals were included as controls. Plasma levels of TMAO and its precursors choline and betaine were measured, and associations with symptoms, aetiology and transplant‐free survival in the patients with HF were explored. Results Plasma levels of TMAO ( P  =   0.01), choline ( P  〈   0.001) and betaine ( P  〈   0.001) were elevated in patients with chronic HF compared to control subjects, with the highest levels in patients with New York Heart Association ( NYHA ) classes III and IV . Furthermore, TMAO levels were highest in individuals with ischaemic HF , followed by those with stable CAD and nonischaemic HF . TMAO , but not choline or betaine, was associated with reduced transplant‐free survival: approximately 50% of patients in the upper tertile of TMAO levels died or received a heart transplant during 5.2 years of follow‐up (unadjusted Cox‐regression: hazard ratio 2.24, 95% confidence interval 1.28–3.92, P  =   0.005). Conclusions TMAO levels were elevated in patients with HF and associated with NYHA class, ischaemic aetiology and adverse outcomes. Future studies should focus on gut microbiota, dietary composition and intestinal dysfunction in relation to TMAO levels and clinical outcome in HF .
    Type of Medium: Online Resource
    ISSN: 0954-6820 , 1365-2796
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2015
    detail.hit.zdb_id: 2006883-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Internal Medicine, Wiley, Vol. 288, No. 4 ( 2020-10), p. 446-456
    Abstract: The carnitine precursor trimethyllysine (TML) is associated with progression of atherosclerosis, possibly through a relationship with trimethylamine‐N‐oxide (TMAO). Riboflavin is a cofactor in TMAO synthesis. We examined prospective relationships of circulating TML and TMAO with acute myocardial infarction (AMI) and potential effect modifications by riboflavin status. Methods By Cox modelling, risk associations were examined amongst 4098 patients (71.8% men) with suspected stable angina pectoris. Subgroup analyses were performed according to median plasma riboflavin. Results During a median follow‐up of 4.9 years, 336 (8.2%) patients experienced an AMI. The age‐ and sex‐adjusted hazard ratio (HR) (95% CI) comparing the 4th vs. 1st TML quartile was 2.19 (1.56–3.09). Multivariable adjustment for traditional cardiovascular risk factors and indices of renal function only slightly attenuated the risk estimates [HR (95% CI) 1.79 (1.23–2.59)], which were particularly strong amongst patients with riboflavin levels above the median ( P int  = 0.035). Plasma TML and TMAO were strongly correlated ( r s  = 0.41; P   〈  0.001); however, plasma TMAO was not associated with AMI risk in adjusted analyses [HR (95% CI) 0.81 (0.58–1.14)]. No interaction between TML and TMAO was observed. Conclusion Amongst patients with suspected stable angina pectoris, plasma TML, but not TMAO, independently predicted risk of AMI. Our results motivate further research on metabolic processes determining TML levels and their potential associations with cardiovascular disease. We did not adjust for multiple comparisons, and the subgroup analyses should be interpreted with caution.
    Type of Medium: Online Resource
    ISSN: 0954-6820 , 1365-2796
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2006883-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...